What is Corcept Therapeutics Incorporated's share price today?
Corcept Therapeutics Incorporated (CORT) share price today is $111.69 as of September 5, 2026 at 1:30 AM IST. The stock touched a day high of $112.02 and a day low of $109.63.What exchange does Corcept Therapeutics Incorporated stock trade on, and under what ticker symbol?
Corcept Therapeutics Incorporated stock trades on NASDAQ under the ticker symbol CORT.What is Corcept Therapeutics Incorporated's market capitalization?
Corcept Therapeutics Incorporated's market capitalization is $11.93B as of September 5, 2026 at 1:30 AM IST.What is Corcept Therapeutics Incorporated's price-to-earnings (P/E) ratio?
Corcept Therapeutics Incorporated's price-to-earnings (P/E) ratio is 245.4 as of September 4, 2026.What is Corcept Therapeutics Incorporated's price-to-book (P/B) ratio?
Corcept Therapeutics Incorporated's price-to-book (P/B) ratio is 17.36 as of September 4, 2026.Can Indian investors buy Corcept Therapeutics Incorporated shares?
Yes, You can buy Corcept Therapeutics Incorporated shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.How can I invest in Corcept Therapeutics Incorporated shares from India?
Indian investors can buy Corcept Therapeutics Incorporated shares in three steps: 1. Search Corcept Therapeutics Incorporated on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.How does USD-INR currency movement affect returns from Corcept Therapeutics Incorporated shares for Indian investors?
Since Corcept Therapeutics Incorporated trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.What is the minimum amount required to invest in Corcept Therapeutics Incorporated shares via Tickertape?
Indian investors can start investing in Corcept Therapeutics Incorporated (CORT) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 0.0895 shares at the current price of $111.69.
$
₹
$111.690.98% (-1.10)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
1D
1W
1M
1Y
5Y
Max
Key Metrics
Key Metrics
PE TTM
PE TTM
Close price divided by the earnings per share for the trailing twelve months
245.4
PB
PB
Close price divided by the book value per share at the end of the most recent quarter
17.36
EPS TTM
EPS TTM
Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)
$0.45
PEG Ratio
PEG Ratio
Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years
0.81
Profit Margin
Profit Margin
Net profit divided by the total revenue for the most recent financial year
6.64%
Dividend Yield
Dividend Yield
Annual dividend per share for the trailing twelve months divided by the close price
—
Analyst Ratings & ForecastAnalyst Ratings & Forecast
Analyst Ratings & Forecast
Analyst Ratings & Forecast
Based on 6 analysts' reports
Buy5 analysts
Hold1 analyst
Sell0 analyst
Analysts expect a +27.68% price upside over the next year
Current Price$111.69
Target Price$141
Company Profile
Peers
Peers
—
—
P/E Ratio
38.91
38.91
—
—
1Y Return
57.39%
57.39%
Buy Reco %
77.41
77.41
—
—
P/E Ratio
31.45
31.45
—
—
1Y Return
55.59%
55.59%
Buy Reco %
45.83
45.83
—
—
P/E Ratio
120.34
120.34
—
—
1Y Return
82.75%
82.75%
Buy Reco %
57.69
57.69
—
—
P/E Ratio
24.32
24.32
—
—
1Y Return
27.18%
27.18%
Buy Reco %
15.38
15.38
—
—
P/E Ratio
24.34
24.34
—
—
1Y Return
0.38%
0.38%
Buy Reco %
90.00
90.00
Peers & Comparison
Peers & Comparison
HealthcareBiotechnology
Valuation
Returns
Forecast
| Stock | PE TTMPE TTM | PBPB | PEG RatioPEG Ratio |
|---|---|---|---|
| Corcept Therapeutics Incorporated | 245.4 | 17.36 | 0.81 |
| Eli Lilly and Company | 38.91 | 30.51 | 1.12 |
| Johnson & Johnson | 31.45 | 7.69 | 4.32 |
Price Comparison
Price Comparison
1 Month
1 Year
5 Years
Financials
Financials
Income
Balance Sheet
Cash Flow
Quarterly Normal View
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Revenue
Net Income
| Financial Year | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 146.80 | 163.79 | 182.54 | 181.89 | 157.21 | 194.43 | 207.63 | 202.12 | 164.90 | 256.14 |
| Gross Profit | 144.27 | 161.27 | 179.67 | 178.93 | 154.81 | 190.99 | 203.04 | 199.58 | 162.02 | 252.08 |
| Net Income | 27.76 | 35.48 | 46.69 | 30.38 | 20.54 | 35.14 | 19.66 | 24.28 | -31.20 | 42.14 |
| Net Profit Margin | 18.91% | 21.66% | 25.57% | 16.70% | 13.06% | 18.07% | 9.47% | 12.01% | -18.92% | 16.45% |